|
Treatment
|
CAT (U/min )
|
SOD (U/mg protein)
|
GSH-Px nM/min/mg protein
|
GSH (μM /min/mg protein)
|
GSR nM/min/mg protein)
|
TBARS(nM /min/mg protein)
|
|---|
|
Control
|
6.0 ± 0.5++
|
18.7 ± 2.8++
|
64.7 ± 3.9++
|
2.12 ± 0. 2++
|
121.7 ± 6.4++
|
29.3 ± 1.2++
|
|
3 ml/kg CCl4
|
2.9 ± 0.6**
|
9.9 ± 0.7**
|
34.2 ± 6.3**
|
1.03 ± 0.3**
|
67.3 ± 3.5**
|
53.17 ± 1.2**
|
|
100 mg/kg SME + CCl4
|
5.0 ± 0.7++
|
16.5 ± 0.7++
|
52.4 ± 7.8++
|
1.90 ± 0.1++
|
111.2 ± 12.4++
|
38.7 ± 2.6++
|
|
200 mg/kg SME + CCl4
|
5.8 ± 0.9++
|
17.5 ± 0.8++
|
62.7 ± 5.6
|
2.03 ± .07
|
122.33 ± 5.28++
|
31.17 ± 1.4++
|
|
100 mg/kg sylimarin + CCl4
|
5.7 ± 0.5++
|
19.4 ± 0.3++
|
60.2 ± 5.3++
|
2.17 ± 0.04++
|
115.3 ± 9.14+
|
30.0 ± 2.7++
|
|
200 mg/kg SME alone
|
5.9 ± 0.6++
|
20.9 ± 0.5++
|
66.8 ± 3.3++
|
2.09 ± 0.2++
|
120.2 ± 6.3++
|
31.2 ± 2.7++
|
- Mean ± SE (n = 6 number).
- **indicate significance from the control group at P < 0.01 probability level.
-
++indicate significance from the CCl4 group at P < 0.01 probability level.
